Covid-19 Impact on Hepatitis B Vaccines Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Hepatitis B Vaccines Industry

1.7 COVID-19 Impact: Hepatitis B Vaccines Market Trends

2 Global Hepatitis B Vaccines Quarterly Market Size Analysis

2.1 Hepatitis B Vaccines Business Impact Assessment - COVID-19

2.1.1 Global Hepatitis B Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Hepatitis B Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Hepatitis B Vaccines Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Hepatitis B Vaccines Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Hepatitis B Vaccines Factory Price by Manufacturers

3.3 Location of Key Manufacturers Hepatitis B Vaccines Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Hepatitis B Vaccines Market

3.5 Key Manufacturers Hepatitis B Vaccines Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Hepatitis B Vaccines Segments, By Type

4.1 Introduction

1.4.1 Mono Vaccines

1.4.2 Combination Vaccines

4.2 By Type, Global Hepatitis B Vaccines Market Size, 2019-2021

4.2.1 By Type, Global Hepatitis B Vaccines Market Size by Type, 2020-2021

4.2.2 By Type, Global Hepatitis B Vaccines Price, 2020-2021

5 Impact of Covid-19 on Hepatitis B Vaccines Segments, By Application

5.1 Overview

5.5.1 adr

5.5.2 adw

5.5.3 ayr

5.5.4 ayw

5.2 By Application, Global Hepatitis B Vaccines Market Size, 2019-2021

5.2.1 By Application, Global Hepatitis B Vaccines Market Size by Application, 2019-2021

5.2.2 By Application, Global Hepatitis B Vaccines Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Business Overview

7.1.2 GlaxoSmithKline Hepatitis B Vaccines Quarterly Production and Revenue, 2020

7.1.3 GlaxoSmithKline Hepatitis B Vaccines Product Introduction

7.1.4 GlaxoSmithKline Response to COVID-19 and Related Developments

7.2 Merck

7.2.1 Merck Business Overview

7.2.2 Merck Hepatitis B Vaccines Quarterly Production and Revenue, 2020

7.2.3 Merck Hepatitis B Vaccines Product Introduction

7.2.4 Merck Response to COVID-19 and Related Developments

7.3 Sanofi Pasteur

7.3.1 Sanofi Pasteur Business Overview

7.3.2 Sanofi Pasteur Hepatitis B Vaccines Quarterly Production and Revenue, 2020

7.3.3 Sanofi Pasteur Hepatitis B Vaccines Product Introduction

7.3.4 Sanofi Pasteur Response to COVID-19 and Related Developments

7.4 Dynavax Technologies

7.4.1 Dynavax Technologies Business Overview

7.4.2 Dynavax Technologies Hepatitis B Vaccines Quarterly Production and Revenue, 2020

7.4.3 Dynavax Technologies Hepatitis B Vaccines Product Introduction

7.4.4 Dynavax Technologies Response to COVID-19 and Related Developments

7.5 Janssen Pharmaceuticals

7.5.1 Janssen Pharmaceuticals Business Overview

7.5.2 Janssen Pharmaceuticals Hepatitis B Vaccines Quarterly Production and Revenue, 2020

7.5.3 Janssen Pharmaceuticals Hepatitis B Vaccines Product Introduction

7.5.4 Janssen Pharmaceuticals Response to COVID-19 and Related Developments

7.6 LG Life Sciences

7.6.1 LG Life Sciences Business Overview

7.6.2 LG Life Sciences Hepatitis B Vaccines Quarterly Production and Revenue, 2020

7.6.3 LG Life Sciences Hepatitis B Vaccines Product Introduction

7.6.4 LG Life Sciences Response to COVID-19 and Related Developments

7.7 KM Biologics

7.7.1 KM Biologics Business Overview

7.7.2 KM Biologics Hepatitis B Vaccines Quarterly Production and Revenue, 2020

7.7.3 KM Biologics Hepatitis B Vaccines Product Introduction

7.7.4 KM Biologics Response to COVID-19 and Related Developments

7.8 Shenzhen Kangtai Biological Products

7.8.1 Shenzhen Kangtai Biological Products Business Overview

7.8.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccines Quarterly Production and Revenue, 2020

7.8.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccines Product Introduction

7.8.4 Shenzhen Kangtai Biological Products Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Hepatitis B Vaccines Supply Chain Analysis

8.1.1 Hepatitis B Vaccines Supply Chain Analysis

8.1.2 Covid-19 Impact on Hepatitis B Vaccines Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Hepatitis B Vaccines Distribution Channels

8.2.2 Covid-19 Impact on Hepatitis B Vaccines Distribution Channels

8.2.3 Hepatitis B Vaccines Distributors

8.3 Hepatitis B Vaccines Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Hepatitis B Vaccines Assessment

Table 9. COVID-19 Impact: Hepatitis B Vaccines Market Trends

Table 10. COVID-19 Impact Global Hepatitis B Vaccines Market Size

Table 11. Global Hepatitis B Vaccines Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Hepatitis B Vaccines Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Hepatitis B Vaccines Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Hepatitis B Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Hepatitis B Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Hepatitis B Vaccines Market Growth Drivers

Table 17. Global Hepatitis B Vaccines Market Restraints

Table 18. Global Hepatitis B Vaccines Market Opportunities

Table 19. Global Hepatitis B Vaccines Market Challenges

Table 20. Key Manufacturers Hepatitis B Vaccines Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Hepatitis B Vaccines Market Size, 2019 (K Units) & (US$ Million)

Table 22. Hepatitis B Vaccines Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Hepatitis B Vaccines Manufacturing Plants

Table 24. Key Manufacturers Hepatitis B Vaccines Market Served

Table 25. Date of Key Manufacturers Enter into Hepatitis B Vaccines Market

Table 26. Key Manufacturers Hepatitis B Vaccines Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Hepatitis B Vaccines Market Size by Type, 2020, (US$ Million)

Table 29. Global Hepatitis B Vaccines Market Size by Type, 2020 (K Units)

Table 30. Global Hepatitis B Vaccines Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Hepatitis B Vaccines Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Hepatitis B Vaccines Market Size by Application, 2020-2021 (K Units)

Table 33. Global Hepatitis B Vaccines Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Hepatitis B Vaccines Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Hepatitis B Vaccines Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Hepatitis B Vaccines Market Size, 2019-2021 (K Units)

Table 38. US Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Hepatitis B Vaccines Market Size, 2019-2021 (K Units)

Table 43. Germany Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Hepatitis B Vaccines Market Size, 2019-2021 (K Units)

Table 50. China Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Hepatitis B Vaccines Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. GlaxoSmithKline Business Overview

Table 58. GlaxoSmithKline Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. GlaxoSmithKline Hepatitis B Vaccines Product

Table 60. GlaxoSmithKline Response to COVID-19 and Related Developments

Table 61. Merck Business Overview

Table 62. Merck Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Merck Hepatitis B Vaccines Product

Table 64. Merck Response to COVID-19 and Related Developments

Table 65. Sanofi Pasteur Business Overview

Table 66. Sanofi Pasteur Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Sanofi Pasteur Hepatitis B Vaccines Product

Table 68. Sanofi Pasteur Response to COVID-19 and Related Developments

Table 69. Dynavax Technologies Business Overview

Table 70. Dynavax Technologies Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Dynavax Technologies Hepatitis B Vaccines Product

Table 72. Dynavax Technologies Response to COVID-19 and Related Developments

Table 73. Janssen Pharmaceuticals Business Overview

Table 74. Janssen Pharmaceuticals Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Janssen Pharmaceuticals Hepatitis B Vaccines Product

Table 76. Janssen Pharmaceuticals Response to COVID-19 and Related Developments

Table 77. LG Life Sciences Business Overview

Table 78. LG Life Sciences Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. LG Life Sciences Hepatitis B Vaccines Product

Table 80. LG Life Sciences Response to COVID-19 and Related Developments

Table 81. KM Biologics Business Overview

Table 82. KM Biologics Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. KM Biologics Hepatitis B Vaccines Product

Table 84. KM Biologics Response to COVID-19 and Related Developments

Table 85. Shenzhen Kangtai Biological Products Business Overview

Table 86. Shenzhen Kangtai Biological Products Hepatitis B Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Shenzhen Kangtai Biological Products Hepatitis B Vaccines Product

Table 88. Shenzhen Kangtai Biological Products Response to COVID-19 and Related Developments

Table 89. Hepatitis B Vaccines Distributors List

Table 90. Hepatitis B Vaccines Customers List

Table 91. Covid-19 Impact on Hepatitis B Vaccines Customers

List of Figures

Figure 1. Hepatitis B Vaccines Product Picture

Figure 2. Hepatitis B Vaccines Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Hepatitis B Vaccines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Hepatitis B Vaccines Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Hepatitis B Vaccines Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Hepatitis B Vaccines Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Hepatitis B Vaccines Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Hepatitis B Vaccines Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Hepatitis B Vaccines Market Size Market Share, 2019-2021